Tag: FDA

FDA: Class I recall of Cordis Precise PRO Rx US Carotid System

Editor's Note The Food and Drug Administration (FDA), on April 26, identified the recall by Cordis Corporation of its Precise PRO Rx US Carotid System as Class I, the most serious. The Carotid System is being recalled due to a risk of separation of the atraumatic distal tip of the…

Read More

By: Judy Mathias
April 27, 2021
Share

FDA, CDC lift pause on J&J COVID-19 vaccine

Editor's Note The US Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC), on April 23, announced that after a thorough safety review, the pause on the Janssen/Johnson & Johnson (J&J) COVID-19 vaccine should be lifted, and use of the vaccine should resume. The pause was…

Read More

By: Judy Mathias
April 26, 2021
Share

FDA: Class I recall of Medtronic’s Extracorporeal Blood Pumping Console

Editor's Note The Food and Drug Administration (FDA), on April 20, identified the recall of Medtronic’s Bio-Console 560 Extracorporeal Blood Pumping Console as Class I, the most serious. The Console is used during heart surgery to pump and return blood to a patient during cardiopulmonary bypass. The recall was initiated…

Read More

By: Judy Mathias
April 22, 2021
Share

FDA issues Class I recall of certain Medtronic ICDs, CRT-Ds

Editor's Note The Food and Drug Administration (FDA), on April 12, identified the recall of Medtronic’s Evera, Viva, Brava, Claria, Amplia, Compia, and Visia implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) as Class I, the most serious. The recall was initiated because of an unexpected and rapid…

Read More

By: Judy Mathias
April 19, 2021
Share

FDA recommends healthcare workers transition away from decontaminated N95 masks

Editor's Note The Food and Drug Administration (FDA), on April 9, sent a letter to healthcare providers recommending they “transition away from crisis capacity conservation strategies,” including disinfection and reuse of N95 masks. Though the FDA believes there is an adequate supply of N95s now to facilitate this transition, the…

Read More

By: Judy Mathias
April 15, 2021
Share

Public perspectives on who should be prioritized for COVID-19 vaccine

Editor's Note In this study from the University of Denver and the University of Pennsylvania, Philadelphia, respondents to two surveys agreed with the National Academies of Science, Engineering, and Medicine’s prioritization framework for COVID-19 vaccination. Of 4,735 respondents (2,730 to a Gallup survey and 2,005 to a COVID Collaborative survey):…

Read More

By: Judy Mathias
April 14, 2021
Share

FDA: Class I recall of Medtronic’s Valiant Navion Thoracic Stent Graft System

Editor's Note The Food & Drug Administration (FDA), on April 9, identified the recall of Medtronic’s Valiant Navion Thoracic Stent Graft System as Class I, the most serious. The recall was initiated because of the risk of stent fractures and endoleak concerns. The system is used to repair lesions of…

Read More

By: Judy Mathias
April 12, 2021
Share

FDA: Class I recall of Medtronic Affinity Pixie Oxygenator and Cardiotomy/Venous Reservoir with Balance Biosurface

Editor's Note The Food and Drug Administration (FDA), on March 24, identified the recall by Medtronic of its Affinity Pixie Oxygenator and Cardiotomy/Venous Reservoir with Balance Biosurface as Class I, the most serious. The recall was issued because of potentially elevated levels of harmful bacterial endotoxins. Use of a device…

Read More

By: Judy Mathias
March 25, 2021
Share

Survey: Healthcare workers’ intentions to receive COVID-19 vaccine

Editor's Note This survey by researchers at the Geisinger Health System, Danville, Pennsylvania, shows a trend of increased intention by healthcare workers to receive a COVID-19 vaccine. A total of 16,292 employees completed the survey, for a response rate of 68.5%. During the period of survey data collection, the researchers…

Read More

By: Judy Mathias
March 23, 2021
Share

FDA: Class I recall of ACIST Kodama Intravascular Ultrasound Catheter

Editor's Note The Food and Drug Administration (FDA), on March 17, identified the recall by ACIST of its Kodama Intravascular Ultrasound Catheter as Class I, the most serious. The recall was initiated because the O-ring housing tubing may squeeze and damage the O-ring. If there is damage, broken O-ring pieces…

Read More

By: Judy Mathias
March 23, 2021
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat